Gritstone bio Inc reports results for the quarter ended in December - Earnings Summary

Gritstone bio

07/03/2024 22:06

* Gritstone bio Inc  GRTS.OQ  reported a quarterly adjusted
loss
of 26 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -30 cents.  The mean expectation of
eight analysts for the quarter was for a loss of 33 cents per
share. Wall Street expected results to range from -42 cents
to -22 cents per share.
    * Revenue rose 143.6% to $10.38 million from a year ago;
analysts
expected $5.11 million. 
    * Gritstone bio Inc's reported EPS for the quarter was a
loss
of 26 cents​.
    * The company reported a quarterly loss of $30.82 million.
    * Gritstone bio Inc shares had risen by 6.9% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 4% in
the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Gritstone
bio Inc
is $7.00 

This summary was machine generated from LSEG data March 7 at
10:05 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.33          -0.26          Beat
 Sep. 30 2023      -0.33          -0.33          Met
 Jun. 30 2023      -0.35          -0.31          Beat
 Mar. 31 2023      -0.33          -0.30          Beat